Guizhou Yibai Pharmaceutical Co Ltd (600594.SS)

600594.SS on Shanghai Stock Exchange

30 Sep 2014
Price Change (% chg)

¥0.31 (+0.83%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 600594.SS


GuiZhou YiBai Pharmaceutical Co., Ltd. is principally engaged in the production and distribution of pharmaceuticals. The Company provides prescription drugs and over the counter (OTC) products, including injections, capsules, oral liquid, granules, tablets and dry powders, among others. It also involves in the provision of... (more)


Beta: 0.18
Market Cap (Mil.): ¥14,853.95
Shares Outstanding (Mil.): 396.00
Dividend: --
Yield (%): 0.32


  600594.SS Industry Sector
P/E (TTM): 30.19 33.37 34.07
EPS (TTM): 1.24 -- --
ROI: 18.28 18.15 17.40
ROE: 19.55 18.85 18.25
Search Stocks

BRIEF-Guizhou Yibai Pharma to acquire Tianjin HorusC&K Pharma for 795 mln yuan

* Says to acquire 100 percent stake in Tianjin Horus C&K Pharma for 795 million yuan ($128.15 million)

07 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime
Provider: Huarong Securities Co., Ltd

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks